OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Peripheral selectivity of the novel cannabinoid receptor antagonist TM 38837 in healthy subjects
Linda E. Klumpers, Marianne Fridberg, Marieke L. de Kam, et al.
British Journal of Clinical Pharmacology (2013) Vol. 76, Iss. 6, pp. 846-857
Open Access | Times Cited: 72
Linda E. Klumpers, Marianne Fridberg, Marieke L. de Kam, et al.
British Journal of Clinical Pharmacology (2013) Vol. 76, Iss. 6, pp. 846-857
Open Access | Times Cited: 72
Showing 1-25 of 72 citing articles:
Endocannabinoids — at the crossroads between the gut microbiota and host metabolism
Patrice D. Cani, Hubert Plovier, Matthias Van Hul, et al.
Nature Reviews Endocrinology (2015) Vol. 12, Iss. 3, pp. 133-143
Closed Access | Times Cited: 313
Patrice D. Cani, Hubert Plovier, Matthias Van Hul, et al.
Nature Reviews Endocrinology (2015) Vol. 12, Iss. 3, pp. 133-143
Closed Access | Times Cited: 313
Cannabis-associated psychosis: Neural substrate and clinical impact
Robin M. Murray, Amir Englund, Anissa Abi‐Dargham, et al.
Neuropharmacology (2017) Vol. 124, pp. 89-104
Closed Access | Times Cited: 177
Robin M. Murray, Amir Englund, Anissa Abi‐Dargham, et al.
Neuropharmacology (2017) Vol. 124, pp. 89-104
Closed Access | Times Cited: 177
Human Laboratory Studies on Cannabinoids and Psychosis
Mohamed Sherif, Rajiv Radhakrishnan, Deepak Cyril D’Souza, et al.
Biological Psychiatry (2016) Vol. 79, Iss. 7, pp. 526-538
Closed Access | Times Cited: 118
Mohamed Sherif, Rajiv Radhakrishnan, Deepak Cyril D’Souza, et al.
Biological Psychiatry (2016) Vol. 79, Iss. 7, pp. 526-538
Closed Access | Times Cited: 118
The therapeutic potential of second and third generation CB1R antagonists
Reşat Çınar, Malliga R. Iyer, George Kunos
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107477-107477
Open Access | Times Cited: 109
Reşat Çınar, Malliga R. Iyer, George Kunos
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107477-107477
Open Access | Times Cited: 109
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 100
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 100
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
Peripherally restricted CB1 receptor blockers
Robert J. Chorvat
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4751-4760
Closed Access | Times Cited: 89
Robert J. Chorvat
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4751-4760
Closed Access | Times Cited: 89
Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review
Jasmine Turna, Sabrina K. Syan, Benício N. Frey, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 4, pp. 550-563
Open Access | Times Cited: 71
Jasmine Turna, Sabrina K. Syan, Benício N. Frey, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 4, pp. 550-563
Open Access | Times Cited: 71
Prospective therapeutic agents for obesity: Molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists
Mayank Sharma, Prashant R. Murumkar, Ashish M. Kanhed, et al.
European Journal of Medicinal Chemistry (2014) Vol. 79, pp. 298-339
Closed Access | Times Cited: 64
Mayank Sharma, Prashant R. Murumkar, Ashish M. Kanhed, et al.
European Journal of Medicinal Chemistry (2014) Vol. 79, pp. 298-339
Closed Access | Times Cited: 64
Peripheral immunomodulation with ginsenoside Rg1 ameliorates neuroinflammation-induced behavioral deficits in rats
Xiao Zheng, Yan Liang, An Kang, et al.
Neuroscience (2013) Vol. 256, pp. 210-222
Closed Access | Times Cited: 63
Xiao Zheng, Yan Liang, An Kang, et al.
Neuroscience (2013) Vol. 256, pp. 210-222
Closed Access | Times Cited: 63
The Use of Biomarkers in Human Pharmacology (Phase I) Studies
Adam F. Cohen, Jacobus Burggraaf, Joop van Gerven, et al.
The Annual Review of Pharmacology and Toxicology (2014) Vol. 55, Iss. 1, pp. 55-74
Open Access | Times Cited: 53
Adam F. Cohen, Jacobus Burggraaf, Joop van Gerven, et al.
The Annual Review of Pharmacology and Toxicology (2014) Vol. 55, Iss. 1, pp. 55-74
Open Access | Times Cited: 53
The role of fatty acids and their endocannabinoid-like derivatives in the molecular regulation of appetite
Renger F. Witkamp
Molecular Aspects of Medicine (2018) Vol. 64, pp. 45-67
Closed Access | Times Cited: 49
Renger F. Witkamp
Molecular Aspects of Medicine (2018) Vol. 64, pp. 45-67
Closed Access | Times Cited: 49
Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases
Joyce M. Richey, Orison O. Woolcott
Current Diabetes Reports (2017) Vol. 17, Iss. 10
Closed Access | Times Cited: 42
Joyce M. Richey, Orison O. Woolcott
Current Diabetes Reports (2017) Vol. 17, Iss. 10
Closed Access | Times Cited: 42
Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice
Haiming Ma, Guina Zhang, Chunrong Mou, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 40
Haiming Ma, Guina Zhang, Chunrong Mou, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 40
Peripheral modulation of the endocannabinoid system in metabolic disease
Nirajan Shrestha, James Cuffe, Dana S. Hutchinson, et al.
Drug Discovery Today (2018) Vol. 23, Iss. 3, pp. 592-604
Open Access | Times Cited: 39
Nirajan Shrestha, James Cuffe, Dana S. Hutchinson, et al.
Drug Discovery Today (2018) Vol. 23, Iss. 3, pp. 592-604
Open Access | Times Cited: 39
Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease
Jonathan Gotfried, Timna Naftali, Ron Schey
Gastroenterology (2020) Vol. 159, Iss. 1, pp. 62-80
Open Access | Times Cited: 35
Jonathan Gotfried, Timna Naftali, Ron Schey
Gastroenterology (2020) Vol. 159, Iss. 1, pp. 62-80
Open Access | Times Cited: 35
Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty
Liliana C. Baptista, Yi Sun, Christy S. Carter, et al.
Frontiers in Nutrition (2020) Vol. 7
Open Access | Times Cited: 34
Liliana C. Baptista, Yi Sun, Christy S. Carter, et al.
Frontiers in Nutrition (2020) Vol. 7
Open Access | Times Cited: 34
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
Thomas W Murphy, Bernard Le Foll
Biomolecules (2020) Vol. 10, Iss. 6, pp. 855-855
Open Access | Times Cited: 33
Thomas W Murphy, Bernard Le Foll
Biomolecules (2020) Vol. 10, Iss. 6, pp. 855-855
Open Access | Times Cited: 33
Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice
Carmelo Quarta, Daniela Cota
International Journal of Obesity (2020) Vol. 44, Iss. 11, pp. 2179-2193
Closed Access | Times Cited: 32
Carmelo Quarta, Daniela Cota
International Journal of Obesity (2020) Vol. 44, Iss. 11, pp. 2179-2193
Closed Access | Times Cited: 32
The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man
Saoirse E. O’Sullivan, Andrew Yates, Richard K. Porter
Molecules (2021) Vol. 26, Iss. 20, pp. 6178-6178
Open Access | Times Cited: 29
Saoirse E. O’Sullivan, Andrew Yates, Richard K. Porter
Molecules (2021) Vol. 26, Iss. 20, pp. 6178-6178
Open Access | Times Cited: 29
Peripheral targets in obesity treatment: a comprehensive update
Antonios Chatzigeorgiou, Eleni Kandaraki, Athanasios G. Papavassiliou, et al.
Obesity Reviews (2014) Vol. 15, Iss. 6, pp. 487-503
Open Access | Times Cited: 37
Antonios Chatzigeorgiou, Eleni Kandaraki, Athanasios G. Papavassiliou, et al.
Obesity Reviews (2014) Vol. 15, Iss. 6, pp. 487-503
Open Access | Times Cited: 37
A novel peripheral cannabinoid receptor 1 antagonist, BPR0912 , reduces weight independently of food intake and modulates thermogenesis
W-C Hsiao, Kak‐Shan Shia, Yu Tian Wang, et al.
Diabetes Obesity and Metabolism (2015) Vol. 17, Iss. 5, pp. 495-504
Closed Access | Times Cited: 35
W-C Hsiao, Kak‐Shan Shia, Yu Tian Wang, et al.
Diabetes Obesity and Metabolism (2015) Vol. 17, Iss. 5, pp. 495-504
Closed Access | Times Cited: 35
Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome
Shira Hirsch, Joseph Tam
Toxins (2019) Vol. 11, Iss. 5, pp. 275-275
Open Access | Times Cited: 32
Shira Hirsch, Joseph Tam
Toxins (2019) Vol. 11, Iss. 5, pp. 275-275
Open Access | Times Cited: 32
A patent update on cannabinoid receptor 1 antagonists (2015-2018)
George Amato, Nayaab S Khan, Rangan Maitra
Expert Opinion on Therapeutic Patents (2019) Vol. 29, Iss. 4, pp. 261-269
Open Access | Times Cited: 30
George Amato, Nayaab S Khan, Rangan Maitra
Expert Opinion on Therapeutic Patents (2019) Vol. 29, Iss. 4, pp. 261-269
Open Access | Times Cited: 30
Understanding the possible role of endocannabinoid system in obesity
Tapan Behl, Swati Chadha, Monika Sachdeva, et al.
Prostaglandins & Other Lipid Mediators (2020) Vol. 152, pp. 106520-106520
Closed Access | Times Cited: 28
Tapan Behl, Swati Chadha, Monika Sachdeva, et al.
Prostaglandins & Other Lipid Mediators (2020) Vol. 152, pp. 106520-106520
Closed Access | Times Cited: 28
